IM Cannabis (IMCC) Amortizatization of Intangibles (2020 - 2026)
IM Cannabis (IMCC) recorded quarterly Amortizatization of Intangibles of $62711.7 in Q1 2026, down 92.09% quarter-over-quarter from $793097.4 in Q4 2025, and up 13.9% on a YoY basis from $55056.4 in Q1 2025.
IM Cannabis (IMCC) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends
IM Cannabis' Amortizatization of Intangibles history runs 7 years deep, the most recent figure standing at $62711.7 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles rose 13.9% year-over-year to $62711.7; the TTM figure through Mar 2026 stood at $966629.9 (up 0.81% YoY), while the FY2025 annual figure was $959461.4, down 4.6% from the prior year.
- Amortizatization of Intangibles was $62711.7 for Q1 2026 at IM Cannabis, down from $793097.4 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $966648.8 in Q4 2023 to a low of $51963.3 in Q2 2025.
- Historically, Amortizatization of Intangibles has averaged $282590.4 across 5 years, with a median of $128684.5 in 2022.
- The sharpest annual moves came in 2022 and 2023: Amortizatization of Intangibles surged 214.3% in 2022, then slumped 82.13% in 2023.
- A 5-year view of Amortizatization of Intangibles shows it stood at $324149.3 in 2022, then jumped by 198.21% to $966648.8 in 2023, then decreased by 18.32% to $789581.6 in 2024, then climbed by 0.45% to $793097.4 in 2025, then slumped by 92.09% to $62711.7 in 2026.
- The last three Amortizatization of Intangibles figures came in at $62711.7 (Q1 2026), $793097.4 (Q4 2025), and $58857.4 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.30 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 242,000.00 |
| 10 | IM Cannabis | 46,600.63 | -738,753.90 | 1.03 Mn | 62,711.69 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 62,711.69 |
| Mar 31, 2026 | 62,711.69 |
| Dec 31, 2025 | 793,097.43 |
| Dec 31, 2025 | 793,097.43 |
| Sep 30, 2025 | 58,857.44 |
| Sep 30, 2025 | 58,857.44 |
| Jun 30, 2025 | 51,963.30 |
| Jun 30, 2025 | 51,963.30 |
| Mar 31, 2025 | 55,056.40 |
| Mar 31, 2025 | 55,056.40 |
| Dec 31, 2024 | 789,581.60 |
| Dec 31, 2024 | 789,581.60 |
| Sep 30, 2024 | 57,178.17 |
| Sep 30, 2024 | 57,178.17 |
| Jun 30, 2024 | 57,028.96 |
| Jun 30, 2024 | 57,028.96 |
| Mar 31, 2024 | 87,569.36 |
| Mar 31, 2024 | 87,569.36 |
| Dec 31, 2023 | 966,648.75 |
| Dec 31, 2023 | 966,648.75 |